loadpatents
name:-0.0207359790802
name:-0.018152952194214
name:-0.0074191093444824
THOREAU; Etienne Patent Filings

THOREAU; Etienne

Patent Applications and Registrations

Patent applications and USPTO patent grants for THOREAU; Etienne.The latest application filed is for "novel mtor inhibitor compounds".

Company Profile
7.17.20
  • THOREAU; Etienne - Saint Vallier de Thiey FR
  • Thoreau; Etienne - Saint-Vallier-de-Thier FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Mtor Inhibitor Compounds
App 20200317683 - CLARY; Laurence ;   et al.
2020-10-08
Novel Mtor Inhibitor Compounds
App 20200317679 - CLARY; Laurence ;   et al.
2020-10-08
Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (T))
Grant 10,752,617 - Musicki , et al. A
2020-08-25
Benzimidazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (T))
Grant 10,618,890 - Musicki , et al.
2020-04-14
Tetrahydroquinoline sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (t))
Grant 10,550,110 - Musicki , et al. Fe
2020-02-04
Benzenesulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR.gamma.(T))
Grant 10,457,637 - Musicki , et al. Oc
2019-10-29
Indazole Sulfonamide Derivatives As Inverse Agonists Of Retinoid-related Orphan Receptor Gamma (ror Gamma (t))
App 20190202819 - MUSICKI; Branislav ;   et al.
2019-07-04
Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR .gamma. (T))
Grant 10,246,440 - Musicki , et al.
2019-04-02
Heterocyclic compounds and use thereof in medicine and in cosmetics
Grant 10,246,422 - Fournier , et al.
2019-04-02
Benzimidazole Sulfonamide Derivatives As Inverse Agonists Of Retinoid-related Orphan Receptor Gamma (ror Gamma (t))
App 20190071433 - MUSICKI; Branislav ;   et al.
2019-03-07
Tetrahydroquinoline Sulfonamide Derivatives As Inverse Agonists Of Retinoid-related Orphan Receptor Gamma (ror Gamma (t))
App 20180265500 - MUSICKI; Branislav ;   et al.
2018-09-20
Benzenesulfonamide Derivatives As Inverse Agonists Of Retinoid-related Orphan Receptor Gamma (ror Gamma (t))
App 20180170869 - MUSICKI; Branislav ;   et al.
2018-06-21
Novel Heterocyclic Compounds And Use Thereof In Medicine And In Cosmetics
App 20180050992 - Fournier; Jean-Francois ;   et al.
2018-02-22
Indazole Sulfonamide Derivatives As Inverse Agonists Of Retinoid-related Orphan Receptor Gamma (ror Gamma (t))
App 20170342062 - MUSICKI; Branislav ;   et al.
2017-11-30
Biphenyl compound selective agonists of gamma RAR receptors
Grant 8,362,082 - Biadatti , et al. January 29, 2
2013-01-29
Biphenyl compound selective agonists of gamma RAR receptors
Grant 8,106,235 - Biadatti , et al. January 31, 2
2012-01-31
Biphenyl Compound Selective Agonists Of Gamma Rar Receptors
App 20120016031 - BIADATTI; Thibaud ;   et al.
2012-01-19
Biphenyl compound selective agonists of gamma RAR receptors
Grant 8,049,034 - Biadatti , et al. November 1, 2
2011-11-01
Methods of modulating PPAR gamma-type receptors
Grant 8,022,079 - Clary , et al. September 20, 2
2011-09-20
Methods for activating PPAR gamma-type receptors
Grant 7,973,063 - Aubert , et al. July 5, 2
2011-07-05
Compounds that modulate PPAR.gamma.-type receptors and cosmetic/pharmaceutical compositions comprising said compounds
Grant 7,968,560 - Clary , et al. June 28, 2
2011-06-28
Compounds that modulate PPAR gamma-type receptors and cosmetic/pharmaceutical compositions comprising said compounds
App 20100247468 - Clary; Laurence ;   et al.
2010-09-30
Methods Of Modulating Ppar Gamma-type Receptors
App 20100099689 - CLARY; Laurence ;   et al.
2010-04-22
Methods for activating PPAR gamma-type receptors
App 20100035988 - Aubert; Jerome ;   et al.
2010-02-11
Compounds that modulate PPAR.gamma. type receptors and cosmetic/pharmaceutical compositions comprised thereof
Grant 7,625,914 - Clary , et al. December 1, 2
2009-12-01
Biaromatic compounds which activate PPAR.gamma.-type receptors and cosmetic/pharmaceutical compositions comprised thereof
Grant 7,626,054 - Aubert , et al. December 1, 2
2009-12-01
Biphenyl compound selective agonists of gamma RAR receptors
App 20090036536 - Biadatti; Thibaud ;   et al.
2009-02-05
Biphenyl compound selective agonists of gamma RAR receptors
App 20090023811 - Biadatti; Thibaud ;   et al.
2009-01-22
Vitamin D analogues
Grant 7,312,249 - Biadatti , et al. December 25, 2
2007-12-25
Novel biaromatic compounds which activate PPARy-type receptors and cosmetic/pharmaceutical compositions comprised thereof
App 20070112070 - Aubert; Jerome ;   et al.
2007-05-17
Novel compounds that modulate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
App 20060148862 - Clary; Laurence ;   et al.
2006-07-06
Novel ligands that modulate LXR-type receptors and cosmetic/pharmaceutical applications thereof
App 20060058351 - Diaz; Philippe ;   et al.
2006-03-16
Novel modulators of the PPAR-type receptors and cosmetic/pharmaceutical compositions comprised thereof
App 20060052627 - Diaz; Philippe ;   et al.
2006-03-09
Novel modulators of the PPAR-type receptors and cosmetic/pharmaceutical compositions comprised thereof
App 20060035969 - Diaz; Philippe ;   et al.
2006-02-16
Novel vitamin D analogues
App 20050182144 - Biadatti, Thibaud ;   et al.
2005-08-18
Polycyclic polyenic compounds and pharmaceutical/cosmetic compositions comprised thereof
Grant 5,910,508 - Thoreau , et al. June 8, 1
1999-06-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed